Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data.

Eun-Bong Lee,Hisashi Yamanaka,Yi Liu,Wen-Chan Tsai,Connie Chen,Kenneth Kwok,Hyun–Jeong Yoo,Lyndon Llamado,Lisy Wang,Yingchun Luo,Naonobu Sugiyama,Yoshiya Tanaka

Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data.

2019

Eun-Bong Lee
Hisashi Yamanaka
Yi Liu
Wen-Chan Tsai
Connie Chen
Kenneth Kwok
Hyun–Jeong Yoo
Lyndon Llamado
Lisy Wang
Yingchun Luo
Naonobu Sugiyama
Yoshiya Tanaka

Aim We report tofacitinib efficacy and safety in Asia‐Pacific patients who participated in the rheumatoid arthritis (RA) clinical development program.

Keywords:

Physical therapy
Diabetes mellitus
Tofacitinib
Medicine
Rheumatoid arthritis
Internal medicine
Incidence (epidemiology)
Placebo
Rheumatology
Adverse effect
Erythrocyte sedimentation rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations